FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia
Clinical trial NCT07645469 · RECRUITING
Trial details
- NCT number
- NCT07645469
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2030-07-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.